TABLE 4.
Mortality | Radiological progression | |||
HR (95% CI) | p-value | HR (95% CI) | p-value | |
MLR | ||||
Age | 1.03 (1.01–1.06) | 0.006* | 1.02 (0.99–1.05) | 0.113 |
Gender | 1.00 (0.74–1.36) | 0.995 | 0.92 (0.67–1.27) | 0.624 |
MLR | 1.16 (1.02–1.31) | 0.025* | 2.28 (1.33–3.87) | 0.002* |
NLR | ||||
Age | 1.03 (1.01–1.06) | 0.007* | 1.02 (0.99–1.05) | 0.122 |
Gender | 0.98 (0.72–1.34) | 0.910 | 0.96 (0.70–1.32) | 0.814 |
NLR | 1.07 (1.05–1.09) | <0.0001* | 1.07 (1.01–1.14) | 0.024* |
SIRI | ||||
Age | 1.04 (1.01–1.06) | 0.003* | 1.03 (0.99–1.05) | 0.079* |
Gender | 1.02 (0.75–1.38) | 0.924 | 0.96 (0.69–1.31) | 0.789 |
SIRI | 1.06 (1.04–1.08) | <0.0001* | 1.09 (1.04–1.14) | 0.0002* |
Each leukocyte index, age and gender is a separate model. Similar findings were observed when leukocyte indexes were adjusted for respiratory comorbidity and when adjusted for coefficient of variation over a year (supplementary tables S3 and S4). MLR: monocyte:lymphocyte ratio; NLR: neutrophil:lymphocyte ratio; SIRI: systemic inflammatory response ((monocytes×neutrophils) ÷ lymphocytes). *: p<0.05.